Federal Pharmaceutical (03933.HK) Rises ~4% on HK$200M Buyback Plan and TUL321 Capsule’s NMPA Clinical Trial Approval
Jun 12, 2026 15:28
CST Updated
16:03
The United Laboratories
Comprehensive pharmaceutical manufacturer